A pharmaceutical delivery system for tracking delivery parameters, the system comprising: a carrier housing (50,140) having a closed end and an open end, wherein the carrier housing defines a cavity; a pharmaceutical agent positionable or positioned within the cavity of the carrier housing; and a cap (20,134) comprising a top end and a bottom end, wherein the bottom end includes a sealing portion that is in physical communication with the open end of the carrier housing to seal the cavity containing the pharmaceutical agent; characterized in that the pharmaceutical delivery system further includes a device (40,136) associated with the system, wherein the device is configured to produce an identifiable current signature for communicating information regarding delivery of a dosage of the pharmaceutical agent, wherein the device is a current control device secured to the cap and configured for producing a unique current signature, wherein the current control device comprises: a conductance control module for producing an identifiable current signature; and a partial power source comprising a first material and a second material insulated from one another and each of the first material and the second material being electrically coupled to the conductance control module, the partial power source of the current control device being configured to produce a voltage potential when the first material and the second material are electrically coupled through a conducting fluid in contact therewith and the voltage potential being used to activate the conductance control module to produce the identifiable current signature. a carrier housing (50,140) having a closed end and an open end, wherein the carrier housing defines a cavity; a pharmaceutical agent positionable or positioned within the cavity of the carrier housing; and a cap (20,134) comprising a top end and a bottom end, wherein the bottom end includes a sealing portion that is in physical communication with the open end of the carrier housing to seal the cavity containing the pharmaceutical agent; characterized in that the pharmaceutical delivery system further includes a device (40,136) associated with the system, wherein the device is configured to produce an identifiable current signature for communicating information regarding delivery of a dosage of the pharmaceutical agent, wherein the device is a current control device secured to the cap and configured for producing a unique current signature, wherein the current control device comprises: a conductance control module for producing an identifiable current signature; and a partial power source comprising a first material and a second material insulated from one another and each of the first material and the second material being electrically coupled to the conductance control module, the partial power source of the current control device being configured to produce a voltage potential when the first material and the second material are electrically coupled through a conducting fluid in contact therewith and the voltage potential being used to activate the conductance control module to produce the identifiable current signature. a conductance control module for producing an identifiable current signature; and a partial power source comprising a first material and a second material insulated from one another and each of the first material and the second material being electrically coupled to the conductance control module, the partial power source of the current control device being configured to produce a voltage potential when the first material and the second material are electrically coupled through a conducting fluid in contact therewith and the voltage potential being used to activate the conductance control module to produce the identifiable current signature.